Moneycontrol PRO
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now

Competition hots up, Groww goes live with stock trading

The startup hopes to introduce futures and options and also intra-day trading over the next few months.

June 11, 2020 / 11:55 AM IST

Bengaluru-based financial services platform Groww has gone live with stock trading, expanding its horizon beyond mutual funds and gold.

After testing the service for a few months, Groww recently opened it for its users, claiming to have already opened one lakh accounts. Moneycontrol was the first to write, on May 28, that Groww was beta testing a stock-trading platform.

“We needed to get the broking licence then build the product which took some time. We have been doing internal testing since October 2019 and added more users in April this year. Now, we are opening it for others as well,” chief executive officer Lalit Keshre told Moneycontrol

Its users had been demand stock trading since 2018 and the company had been working on it for quite some time.

The company was targeting the next million investors, young traders who would be attracted to the product because of the simplicity and the user friendliness of the platform, he said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Having started with buying and selling of stocks, the startup is working on futures and options trading, intra-day trading and others features that it hopes to take live over the next few months.

Any new player in a space has to go up against the incumbents and in stock-trading, Groww will have to fight for its share with the largest stock-broker in the country Zerodha, another tech startup.

ALSO READ: Zerodha makes TOTP mandatory to counter phishing; here is how to get one

Speaking of competition, Keshre said that they were trying to make stock-trading more democratic and expand the market.

“When we had entered into mutual funds, there were already entrenched players there, even in stock-trading, there is competition but our aim is to grow the market and chase new investors and traders,” he said.

During a previous interaction Abhishant Pant, an angel investor in fintech startups, had said the coronavirus outbreak had thrown up opportunities as well as challenges for new players in the fintech ecosystem.

Groww could leverage the growing interest among Indians in stock trading as many were trying to lap up some scrips cheap during the pandemic, he said.

Given the economic stress, many investors with surplus wealth might chose to save money rather than invest it and that was a challenge.

“Markets cannot be predicted, we can only create good products and offer de-risking capabilities to our investors, we are building Groww along those principles,” Keshre said.

Groww was launched in 2017 by former Flipkart executives Keshre, Harsh Jain, Neeraj Singh and Ishan Bansal. The startup is backed by YCombinator, Sequoia Capital and Ribbit Capital.

In terms of equity support, Keshre said they were in a comfortable position as a low burn gave them quite a long runway.
Invite your friends and family to sign up for MC Tech 3, our daily newsletter that breaks down the biggest tech and startup stories of the day

Pratik Bhakta
first published: Jun 11, 2020 11:46 am